Pegylated Interferon/Ribavirin dual therapy in patients with chronic Hepatitis C: results of 323 cases
Objective: The combination of pegylated interferon-α (PEG-IFN) and ribavirin has become a mainstay in the treatment of chronic hepatitis C (CHC). We aimed to evaluate the efficacy of this treatment in patients with CHC, while considering new approaches. Methods: A total of 323 patients with CHC und...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Eldaghayes Publisher
2015-12-01
|
| シリーズ: | Journal of Microbiology and Infectious Diseases |
| 主題: | |
| オンライン･アクセス: | http://www.jmidonline.org/upload/sayi/23/JMID-00941.pdf |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|